BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9204976)

  • 1. Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML).
    Martinet D; Mühlematter D; Leeman M; Parlier V; Hess U; Gmür J; Jotterand M
    Leukemia; 1997 Jul; 11(7):964-70. PubMed ID: 9204976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.
    Marlton P; Claxton DF; Liu P; Estey EH; Beran M; LeBeau M; Testa JR; Collins FS; Rowley JD; Siciliano MJ
    Blood; 1995 Feb; 85(3):772-9. PubMed ID: 7833479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
    Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
    Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.
    Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
    Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
    Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
    Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'CBFbeta deletion associated with inv(16) in acute myeloid leukemia.
    Kelly J; Foot NJ; Conneally E; Enright H; Humphreys M; Saunders K; Neat MJ
    Cancer Genet Cytogenet; 2005 Oct; 162(2):122-6. PubMed ID: 16213359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A dual-color fluorescence in situ hybridization study on the detection of inv(16) in acute myeloid leukemia].
    Li M; Xue YQ; Wu YF; Pan JL; Yao L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):331-5. PubMed ID: 12903046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
    Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
    Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.
    Hernández JM; González MB; Granada I; Gutiérrez N; Chillón C; Ramos F; Ribera JM; González M; Feliu E; San Miguel J
    Haematologica; 2000 May; 85(5):481-5. PubMed ID: 10800163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement between the MYH11 gene at 16p13 and D12S158 at 12p13 in a case of acute myeloid leukemia M1 (AML-M1).
    La Starza R; Wlodarska I; Matteucci C; Falzetti D; Baens M; Martelli MF; Van den Berghe H; Marynen P; Mecucci C
    Genes Chromosomes Cancer; 1998 Sep; 23(1):10-5. PubMed ID: 9713991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16.
    Pirc-Danoewinata H; Dauwerse HG; König M; Chudoba I; Mitterbauer M; Jäger U; Breuning MH; Haas OA
    Genes Chromosomes Cancer; 2000 Oct; 29(2):186-91. PubMed ID: 10959099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of trisomy 22 and inversion 16 in acute myeloid leukemia].
    Zhou HF; Li JY; Pan JL; Qiu HR; Chen LJ; Hu JY; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):11-4. PubMed ID: 17649718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.
    Martinez-Climent JA; Comes AM; Vizcarra E; Reshmi S; Benet I; Marugan I; Tormo M; Terol MJ; Solano C; Arbona C; Prosper F; Barragan E; Bolufer P; Rowley JD; García-Conde J
    Cancer Genet Cytogenet; 1999 Apr; 110(2):111-4. PubMed ID: 10214358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
    Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
    Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.